ANTX
ANTX
NASDAQ · Pharmaceuticals

An2 Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$4.00
+0.09 (+2.30%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +363.8% upside
Low Target $11.23
Average Target $18.55
High Target $22.80
Current Price $4.00
Current
$4.00
Target
$18.55
$11.23 $18.55 avg $22.80
Scenario Analysis
Bear Case
$11.23
180.8%
Low target
Base Case
$18.55
+363.8%
Avg target
Bull Case
$22.80
+470.0%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$6.91
-42.1% from high
52-Week Low
$1.00
+300.0% from low
Target vs 52W High
$18.55
+168.5% vs high
Next Earnings Report
Apr 1, 2026 · After Market Close
5d
until earnings
EPS Est: $-0.24
Earnings in 5 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%